Catalytic RNA molecules that accelerate chemical reactions — chiefly phosphodiester bond cleavage, ligation, and peptide bond synthesis — without requiring a protein active site. Identified in 1982, when Kelly Kruger, Thomas Cech, and colleagues showed that the Tetrahymena thermophila 26S ribosomal RNA intron excises itself in the complete absence of protein, and corroborated in 1983 by Cecilia Guerrier-Takada, Sidney Altman, and colleagues showing that the RNA subunit of ribonuclease P is the true catalytic moiety, ribozymes overturned the dogma that all biological enzymes are proteins.
Class
Catalytic ribonucleic acid (RNA enzyme; self-cleaving, splicing, and peptidyl-transfer classes)
Typical Length
~40–85 nt (small self-cleaving hammerhead/HDV/twister motifs) to >300–5,000 nt (RNase P, introns, 28S rRNA)
80S ribosome, major/minor spliceosome (U2–U6), and the nuclear RNase P holoenzyme (human mitochondrial RNase P is a protein-only enzyme)
Primary Function
RNA transesterification, phosphodiester hydrolysis, pre-tRNA 5' maturation, and peptide bond catalysis
Clinical / Biotech Use
Self-cleaving ribozyme switches for gene-therapy expression control, HDV viral replication target, and precise gRNA processing
Structure & Biogenesis
Unlike deoxyribonucleic acid (DNA), RNA possesses a reactive 2'-hydroxyl (2'-OH) group on every ribose ring and folds into intricate tertiary pseudoknots, coaxially stacked helices, and divalent metal-ion (Mg²⁺) binding pockets that position general acid–base nucleobases.
Natural ribozymes fall into two structural categories: large ribozymes (over 200 nucleotides, including Group I and Group II self-splicing introns, the U2/U6 spliceosome core, RNase P, and 28S/23S rRNA) and small self-cleaving ribozymes (40 to 150 nucleotides, including hammerhead, hairpin, hepatitis delta virus [HDV], Varkud satellite, twister, and pistol motifs).
Mechanism of Action
Small self-cleaving ribozymes use general acid–base catalysis (often via shifted pKa values of active-site guanine and adenine bases) to deprotonate an internal 2'-OH group, which attacks the adjacent 3',5'-phosphodiester phosphorus atom in an inline SN2 transphosphorylation — the same chemical intermediate produced by protein ribonuclease A — yielding a 2',3'-cyclic phosphate terminus and a 5'-hydroxyl product. Large splicing and processing ribozymes (Group I/II introns, the snRNA spliceosome, and RNase P) instead coordinate two catalytic magnesium ions (Mg²⁺) in their active site to activate an exogenous nucleophile (a guanosine 3'-OH, a branch-point adenosine 2'-OH, or a water molecule), leaving 3'-hydroxyl and 5'-phosphate termini.
Biological & Regulatory Roles
Universal cellular machines: The three core RNA-processing reactions of human cells — peptide bond synthesis in the ribosome (28S rRNA), pre-mRNA intron removal in the spliceosome (U6/U2 snRNA), and 5' leader cleavage of pre-tRNA by nuclear RNase P (H1 RNA / RPPH1) — are all catalyzed by ribozyme active sites.
Mammalian self-cleaving motifs: Conserved hammerhead-like and CPEB3 (HDV-like) self-cleaving ribozymes are embedded within human introns and 3' UTRs, and the 3' ends of nuclear lncRNAs MALAT1 and NEAT1 are processed by the RNase P ribozyme.
Interactions & Complexes
Although the RNA moiety provides the catalytic active site, human ribozymes associate with auxiliary proteins (such as the 10 protein subunits of human nuclear RNase P) that shield negatively charged phosphate backbones and accelerate substrate turnover.
Therapeutic & Biotechnology Applications
Hepatitis delta virus (HDV), a satellite virus of hepatitis B in the liver, depends on an 85-nt genomic and antigenomic HDV ribozyme for rolling-circle replication.
In synthetic biology and CRISPR-Cas9 delivery, flanking a guide RNA with 5' hammerhead and 3' HDV self-cleaving ribozymes allows precise excision of functional gRNAs from standard RNA polymerase II transcripts, while ligand-responsive aptazymes (aptamer + ribozyme fusions) act as small-molecule-controlled mRNA "off/on" switches in gene therapy.